TRUQAP Patient Assistance Program
Don’t let breast cancer treatment costs derail precision oncology. We help eligible
patients access Truqap (capivasertib) for as little as $69.95 per month through
manufacturer Patient Assistance Programs.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Truqap Is The First And Only AKT Inhibitor — A New Class Of Targeted Cancer Therapy For HR+/HER2- Advanced Breast Cancer With Specific PIK3CA, AKT1, Or PTEN Gene Alterations
- Retail Cost Is Approximately $23,070 Per 28-Day Cycle Without Insurance, Totaling Over $276,000 Per Year
- AffordMyPrescriptions Provides Access To Truqap For Just $69.95/Month Through The Patient Assistance Program
- No Generic Version Of Capivasertib Is Available, And None Is Expected For Many Years
What Is Truqap Prescription Assistance Program?
The Truqap Prescription Assistance Program is a manufacturer-sponsored initiative that provides Truqap at no medication cost to qualifying patients who cannot afford it. The program is accessible through the manufacturer’s patient support services. Financial assistance is available for commercially
insured patients, uninsured patients, and those who have been denied insurance coverage. Eligibility is determined on a case-by-case basis.
When your breast cancer has progressed on hormone therapy and genetic testing reveals that your tumor carries PIK3CA, AKT1, or PTEN alterations — meaning a first-in-class targeted therapy exists that specifically attacks the molecular pathway fueling your cancer — the hope is transformative. Discovering that this breakthrough medication costs over $23,000 per month can make that hope feel cruelly out of reach.
AffordMyPrescriptions ensures that your tumor’s genetic profile, not your financial situation, determines whether you can access the latest precision oncology treatment. For a flat $69.95 per month, our Patient Advocates manage every step of your enrollment with the urgency your diagnosis demands.
Pharmacy Price Comparison
- Without assistance, Airsupra costs hundreds of dollars or more per month at retail pharmacies. Discount programs offer some relief, but they don’t come close to what a Patient Assistance Program provides, if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Specialty Rx | ~$23,070.00 | Save ~$23,000/mo |
| CVS Specialty | ~$23,100.00 | Save ~$23,030/mo |
| Walgreens | ~$23,050.00 | Save ~$22,980/mo |
| Specialty Net. | ~$23,080.00 | Save ~$23,010/mo |
| Mail-Order | ~$23,070.00 | Save ~$23,000/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Truqap Prescription Program?
When your breast cancer has progressed despite hormone therapy and your oncologist prescribes a first-in-class targeted therapy that matches your tumor’s specific genetic profile, the complexity of accessing a $23,000-per-month specialty medication can feel like an impossible obstacle on top of an already devastating situation. Insurance prior authorizations, companion diagnostic testing coordination, specialty pharmacy logistics, and the emotional weight of managing advanced cancer all compete for your limited energy.
Our trained Patient Advocates specialize in precision oncology medication access and manage every administrative detail on your behalf. From the moment you enroll, your advocate prepares your application, coordinates with your oncologist (including companion diagnostic test results confirming your PIK3CA, AKT1, or PTEN alteration), submits everything to the appropriate program, and tracks your status through every stage. When refills are due, they coordinate with your specialty pharmacy proactively.
Our pricing is simple and predictable: $69.95 per month — every month. While the medication itself is provided at no cost through the manufacturer’s program, our monthly fee covers all advocacy, application management, oncologist coordination, and specialty pharmacy oversight. If we’re unable to secure access, you won’t be charged.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long–term solution:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Cards expire and require constant renewal
- Subject to strict monthly or annual maximum savings caps
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly from the manufacturer
- We manage all paperwork, refills, and renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements can vary, we encourage you to contact AffordMyPrescriptions directly
so we can review your specific situation.
- You are a U.S. citizen or legal resident
- You Have a Valid Airsupra Prescription From a Licensed U.S. Healthcare Provider
- You are uninsured or underinsured and cannot afford your medication at current pharmacy prices
- You Have Medicare Part D and Are Struggling With Out-of-Pocket Drug Costs
- You Have Recently Experienced a Change in Financial Circumstances That Affects Your Ability to Pay
Understanding Truqap:
Truqap (capivasertib) is a prescription oral tablet used in combination with fulvestrant to treat adults with hormone receptor-positive (HR+), HER2-negative locally advanced or metastatic breast cancer that has one or more PIK3CA, AKT1, or PTEN gene alterations, and that has progressed on or after endocrine-based therapy. It is the first and only FDA-approved AKT inhibitor. Available in 160 mg and 200 mg tablets, taken as 400 mg twice daily on a 4-days-on, 3-days-off schedule.
How It Works:
In many HR-positive breast cancers that have become resistant to hormone therapy, the cancer cells have found a way to keep growing by activating a signaling pathway called the PI3K/AKT pathway. This pathway acts like an accelerator pedal for cell growth — and in approximately half of resistant breast cancers, one of three genes (PIK3CA, AKT1, or PTEN) has mutated or been altered, causing the AKT protein to become permanently overactive.
Truqap is the first medication designed to directly block the AKT protein itself. When you take Truqap, the capivasertib molecule enters the cancer cell and binds to all three versions of the AKT enzyme (AKT1, AKT2, and AKT3), preventing them from sending growth signals. With AKT blocked, the cancer cells lose the survival advantage that made them resistant to hormone therapy. Truqap is taken in combination with fulvestrant, creating a two-pronged attack against estrogen-driven cancer growth.
Form and Use:
Available in 160 mg and 200 mg tablets. Take 400 mg (two tablets) twice daily for 4 consecutive days, then take no Truqap for 3 days. This 4-days-on, 3-days-off cycle repeats continuously. Take with or without food. Always used in combination with fulvestrant injections on a separate schedule. Dispensed through specialty pharmacies.
Generic Availability:
As of April 2026, there is no generic version of Truqap (capivasertib) available in the United States. Truqap was first approved in November 2023 and remains under full patent protection. As a first-in-class AKT inhibitor with no other drugs in its specific class approved in the U.S., generic competition is not expected for many years.
Until a generic becomes available, the Patient Assistance Program through AffordMyPrescriptions provides Truqap at no medication cost for $69.95 per month — the only realistic access pathway for uninsured patients facing approximately $23,070 per 28-day treatment cycle.
Warnings:
Truqap may cause serious side effects including hyperglycemia (high blood sugar), diarrhea, and severe skin reactions. Tell your healthcare provider about all your medical conditions, especially diabetes. Companion diagnostic testing is required before starting treatment. Common side effects include diarrhea, nausea, fatigue, vomiting, and rash.
FAQ (Frequently Asked Questions)
How Much Does Truqap Cost Without Insurance?
Truqap costs approximately $23,070 per 28-day cycle ($276,000+ per year). The manufacturer offers a $0 copay program for commercially insured patients. Through AffordMyPrescriptions, qualifying patients receive Truqap at no medication cost — our $69.95 monthly fee covers advocacy and program management.
Is This The Same Truqap I'd Get At A Pharmacy?
Yes. The Truqap supplied through the Patient Assistance Program is the same FDA-approved capivasertib medication dispensed at specialty pharmacies, supplied directly from the manufacturer.
Do I Need Genetic Testing To Qualify For Truqap?
Yes. Truqap requires confirmation that your breast cancer has one or more PIK3CA, AKT1, or PTEN gene alterations through an FDA-approved companion diagnostic test (such as FoundationOne CDx). Your oncologist will order this testing on a tumor tissue sample or blood sample.
Can I Get Truqap Through The PAP If I Have Medicare?
Yes. Medicare patients may qualify for the Patient Assistance Program. As of 2026, Medicare Part D plans also have a $2,100 annual out-of-pocket cap. Our advocates can help you evaluate the best pathway.
Take Control of Your Medication Costs
If you are struggling with the high cost of Truqap, our team may be able to help you access assistance programs designed to make medications more affordable. Check your eligibility today and take the first step toward reducing your prescription costs.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.